Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kymera Therapeutics (KYMR) Change in Accured Expenses (2019 - 2025)

Kymera Therapeutics (KYMR) has disclosed Change in Accured Expenses for 7 consecutive years, with $13.7 million as the latest value for Q4 2025.

  • Quarterly Change in Accured Expenses rose 51.43% to $13.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $7.4 million through Dec 2025, up 76.72% year-over-year, with the annual reading at $7.4 million for FY2025, 76.72% up from the prior year.
  • Change in Accured Expenses for Q4 2025 was $13.7 million at Kymera Therapeutics, up from $664000.0 in the prior quarter.
  • The five-year high for Change in Accured Expenses was $13.7 million in Q4 2025, with the low at -$15.4 million in Q1 2024.
  • Average Change in Accured Expenses over 5 years is $1.6 million, with a median of $3.1 million recorded in 2022.
  • The sharpest move saw Change in Accured Expenses soared 642.74% in 2021, then tumbled 1069.36% in 2022.
  • Over 5 years, Change in Accured Expenses stood at $3.8 million in 2021, then decreased by 25.13% to $2.8 million in 2022, then skyrocketed by 139.02% to $6.8 million in 2023, then soared by 32.81% to $9.0 million in 2024, then soared by 51.43% to $13.7 million in 2025.
  • According to Business Quant data, Change in Accured Expenses over the past three periods came in at $13.7 million, $664000.0, and $4.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.